Gary Remington

Gary Remington

UNVERIFIED PROFILE

Are you Gary Remington?   Register this Author

Register author
Gary Remington

Gary Remington

Publications by authors named "Gary Remington"

Are you Gary Remington?   Register this Author

100Publications

2465Reads

46Profile Views

Identity, Subjectivity, and Disorders of Self in Psychosis.

Cult Med Psychiatry 2019 Sep;43(3):442-467

Department of Psychiatry, The University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11013-019-09631-y
Publisher Site
http://dx.doi.org/10.1007/s11013-019-09631-yDOI Listing
September 2019

Modulation of brain activity with transcranial direct current stimulation: Targeting regions implicated in impaired illness awareness in schizophrenia.

Eur Psychiatry 2019 Sep 19;61:63-71. Epub 2019 Jul 19.

Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health, (CAMH), University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Geriatric Mental Health Division, CAMH, University of Toronto, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, CAMH, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eurpsy.2019.06.007DOI Listing
September 2019

Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study.

Eur Arch Psychiatry Clin Neurosci 2019 Aug 19. Epub 2019 Aug 19.

Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), 250 College Street, Toronto, ON, M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00406-019-01053-6DOI Listing
August 2019

Clozapine and tardive dyskinesia in patients with schizophrenia: A systematic review.

J Psychopharmacol 2019 Jul 26:269881119862535. Epub 2019 Jul 26.

1 Schizophrenia Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0269881119862535DOI Listing
July 2019

Can Aripiprazole Worsen Psychosis in Schizophrenia? A Meta-Analysis of Double-Blind, Randomized, Controlled Trials.

J Clin Psychiatry 2018 Mar/Apr;79(2)

Schizophrenia Division, Complex Care & Recovery Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.17r11489DOI Listing
June 2019

Alterations in body mass index and waist-to-hip ratio in never and minimally treated patients with psychosis: A systematic review and meta-analysis.

Schizophr Res 2019 Jun 23;208:420-429. Epub 2019 Jan 23.

Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Geriatric Mental Health Division, CAMH, University of Toronto, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, CAMH, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2019.01.005DOI Listing
June 2019

Treatment Recommendations for Tardive Dyskinesia.

Can J Psychiatry 2019 Jun 21;64(6):388-399. Epub 2019 Feb 21.

1 Neurosciences Research Centre, Molecular and Clinical Sciences Institute, St George's University of London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0706743719828968DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6591749PMC
June 2019

Clozapine-Related Myocarditis and Rechallenge: A Case Series and Clinical Review.

J Clin Psychopharmacol 2019 Jul/Aug;39(4):380-385

Schizophrenia Division, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0000000000001062DOI Listing
June 2019

Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study.

Biol Psychiatry 2019 04 26;85(7):596-605. Epub 2018 Sep 26.

Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Geriatric Mental Health Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Campbell Institute Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00063223183185
Publisher Site
http://dx.doi.org/10.1016/j.biopsych.2018.09.009DOI Listing
April 2019

Reward-driven decision-making impairments in schizophrenia.

Schizophr Res 2019 Apr 12;206:277-283. Epub 2018 Nov 12.

Centre for Addiction and Mental Health, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2018.11.004DOI Listing
April 2019

Goal-directed planning and action impairments in schizophrenia evaluated in a virtual environment.

Schizophr Res 2019 Apr 22;206:400-406. Epub 2018 Nov 22.

Schizophrenia Division and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College St., Toronto, Ontario M5T 1R8, Canada; Institute of Medical Science, Faculty of Medicine, University of Toronto, Medical Sciences Building, 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada; Department of Psychiatry, University of Toronto, 250 College St., Toronto, Ontario M5T 1R8, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09209964183061
Publisher Site
http://dx.doi.org/10.1016/j.schres.2018.10.012DOI Listing
April 2019

Clozapine-induced myocarditis in Canada: Evidence from spontaneous reports.

Schizophr Res 2019 Apr 1;206:462-463. Epub 2018 Dec 1.

Schizophrenia Division, Centre for Addiction and Mental Health, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09209964183066
Publisher Site
http://dx.doi.org/10.1016/j.schres.2018.11.015DOI Listing
April 2019

Patient versus rater evaluation of symptom severity in treatment resistant schizophrenia receiving clozapine.

Psychiatry Res 2019 04 20;274:409-413. Epub 2019 Feb 20.

Schizophrenia Division, Centre for Addiction and Mental Health, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2019.02.050DOI Listing
April 2019

A meta-analysis of transcranial direct current stimulation for schizophrenia: "Is more better?"

J Psychiatr Res 2019 Mar 10;110:117-126. Epub 2018 Dec 10.

Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Geriatric Mental Health Division, CAMH, University of Toronto, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, CAMH, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2018.12.009DOI Listing
March 2019

What proportion of striatal D2 receptors are occupied by endogenous dopamine at baseline? A meta-analysis with implications for understanding antipsychotic occupancy.

Neuropharmacology 2019 Mar 30. Epub 2019 Mar 30.

Research Imaging Centre, Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario, M5T 1R8, Canada; Department of Psychiatry, University of Toronto, 250 College Street, Toronto, Ontario, M5T 1R8, Canada; Institute of Medical Science, University of Toronto, 1 Kings College Circle, Toronto, Ontario, M5S 1A8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuropharm.2019.03.034DOI Listing
March 2019

Genetic study of neuregulin 1 and receptor tyrosine-protein kinase erbB-4 in tardive dyskinesia.

World J Biol Psychiatry 2019 01 10;20(1):91-95. Epub 2017 Apr 10.

a Neurogenetics Section, Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science , Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health , Toronto , ON , Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/15622975.2017.1301681DOI Listing
January 2019

Antipsychotics and glucose metabolism: how brain and body collide.

Am J Physiol Endocrinol Metab 2019 Jan 3;316(1):E1-E15. Epub 2018 Jul 3.

Centre for Addiction and Mental Health , Toronto, Ontario , Canada.

View Article

Download full-text PDF

Source
https://www.physiology.org/doi/10.1152/ajpendo.00164.2018
Publisher Site
http://dx.doi.org/10.1152/ajpendo.00164.2018DOI Listing
January 2019

Revisiting the International Physical Activity Questionnaire (IPAQ): Assessing sitting time among individuals with schizophrenia.

Psychiatry Res 2019 01 27;271:311-318. Epub 2018 Nov 27.

School of Kinesiology, University of British Columbia, 2148 Health Sciences Mall, Room 4008, Vancouver, BC V6T 1Z8, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01651781183142
Publisher Site
http://dx.doi.org/10.1016/j.psychres.2018.11.063DOI Listing
January 2019

Achievement motivation in early schizophrenia: Relationship with symptoms, cognition and functional outcome.

Early Interv Psychiatry 2018 12 23;12(6):1038-1044. Epub 2017 Feb 23.

Schizophrenia Division and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/eip.12405
Publisher Site
http://dx.doi.org/10.1111/eip.12405DOI Listing
December 2018

Effects of acute olanzapine exposure on central insulin-mediated regulation of whole body fuel selection and feeding.

Psychoneuroendocrinology 2018 12 30;98:127-130. Epub 2018 Jul 30.

Centre for Addiction and Mental Health, 250 College St, Toronto, ON, M5T 1R8, Canada; Institute of Medical Sciences, University of Toronto, 1 King's College Circle, Toronto, ON, M5S 1A8T, Canada; Department of Psychiatry, University of Toronto, 250 College Street, 8th Floor, Toronto, ON, M5T 1R8, Canada; Banting and Best Diabetes Centre, Eaton Building, Room 12E248, 200 Elizabeth St, Toronto, ON M5G 2C4, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psyneuen.2018.07.028DOI Listing
December 2018

Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia.

Neurosci Lett 2018 11 15;686:17-22. Epub 2018 Aug 15.

Neurogenetics Section, Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science Department, Campbell Family Mental Health Research Institute, CAMH, Canada; Institute of Medical Science, University of Toronto, Canada; Department of Psychiatry, University of Toronto, Canada; Laboratory Medicine and Pathobiology, University of Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://www.sciencedirect.com/journal/neuroscience-letters/v
Web Search
https://academic.oup.com/ntr/article-abstract/11/4/404/11007
Web Search
https://academic.oup.com/schizophreniabulletin/article/21/2/
Web Search
https://linkinghub.elsevier.com/retrieve/pii/S03043940183053
Publisher Site
http://dx.doi.org/10.1016/j.neulet.2018.08.007DOI Listing
November 2018

Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry.

Exp Eye Res 2018 10 5;175:32-41. Epub 2018 Jun 5.

Research Imaging Centre, Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario, M5T 1R8, Canada; Department of Psychiatry, University of Toronto, 250 College Street, Toronto, Ontario, M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exer.2018.06.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167174PMC
October 2018

The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review.

Psychiatry Res 2018 10 9;268:114-122. Epub 2018 Jul 9.

Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Geriatric Mental Health Division, CAMH, University of Toronto, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, CAMH, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01651781183056
Publisher Site
http://dx.doi.org/10.1016/j.psychres.2018.06.070DOI Listing
October 2018

The neural correlates of apathy in schizophrenia: An exploratory investigation.

Neuropsychologia 2018 09 25;118(Pt B):34-39. Epub 2017 Oct 25.

Research Imaging Centre, Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario, Canada M5T 1R8; Department of Psychiatry, University of Toronto, 250 College Street, Toronto, Ontario, Canada M5T 1R8.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00283932173040
Publisher Site
http://dx.doi.org/10.1016/j.neuropsychologia.2017.10.027DOI Listing
September 2018

Objective investigation of activity preference in schizophrenia: A pilot study.

Psychiatry Res 2018 09 16;267:551-559. Epub 2018 May 16.

Schizophrenia Division and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College St., Toronto, Ontario M5T 1R8, Canada.; Institute of Medical Science, Faculty of Medicine, University of Toronto, Medical Sciences Building, 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada.; Department of Psychiatry, University of Toronto, 250 College St., Toronto, Ontario M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2018.05.039DOI Listing
September 2018

Neurometabolite levels in antipsychotic-naïve/free patients with schizophrenia: A systematic review and meta-analysis of H-MRS studies.

Prog Neuropsychopharmacol Biol Psychiatry 2018 08 23;86:340-352. Epub 2018 Mar 23.

Multimodal Imaging Group, Research Imaging Centre, Centre for Addiction and Mental Health, 250 College Street, M5T 1R8 Toronto, Ontario, Canada.; Department of Psychiatry, University of Toronto, 250 College Street, M5T 1R8 Toronto, Ontario, Canada; Geriatric Mental Health Division, Centre for Addiction and Mental Health, 80 Workman Way, M6J 1H4 Toronto, Canada; Campbell Research Institute, Centre for Addiction and Mental Health, 1001 Queen St. W, M6J 1H4 Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pnpbp.2018.03.016DOI Listing
August 2018

Genetics of tardive dyskinesia: Promising leads and ways forward.

J Neurol Sci 2018 06 5;389:28-34. Epub 2018 Feb 5.

Neurogenetics Section, Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Canada; Department of Psychiatry, University of Toronto, Canada; Institute of Medical Science, University of Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2018.02.011DOI Listing
June 2018

Objective assessment of exploratory behaviour in schizophrenia using wireless motion capture.

Schizophr Res 2018 05 24;195:122-129. Epub 2017 Sep 24.

Schizophrenia Division and Campbell Family Research Institute, Centre for Addiction and Mental Health, 250 College St., Toronto, Ontario M5T 1R8, Canada; Institute of Medical Science, Faculty of Medicine, University of Toronto, Medical Sciences Building, 1 King's College Circle, Toronto, Ontario M5S 1A8, Canada; Department of Psychiatry, University of Toronto, 250 College St., Toronto, Ontario M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2017.09.011DOI Listing
May 2018

Use of Placebo in Clinical Trials of Psychotropic Medication.

Can J Psychiatry 2018 05;63(5):338-341

5 Professor and BC Leadership Chair in Depression Research, Department of Psychiatry, University of British Columbia; Director, Mood Disorders Centre, Djavad Mowafaghian Centre for Brain Health, Vancouver, British Columbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0706743717752917DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912304PMC
May 2018

Improving outcomes in schizophrenia by preventing early relapses.

Lancet Psychiatry 2018 05;5(5):384-386

Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Centre for Addiction and Mental Health, Toronto M6J 1H4, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2215-0366(18)30124-XDOI Listing
May 2018

Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls.

Schizophr Res 2018 04 9;194:55-61. Epub 2017 Mar 9.

The Institute of Medical Sciences (IMS), University of Toronto, Toronto, Ontario, Canada; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2017.03.010DOI Listing
April 2018

A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls.

Schizophr Res 2018 04 12;194:47-54. Epub 2017 May 12.

The Institute of Medical Sciences (IMS), University of Toronto, Toronto, Ontario, Canada; Schizophrenia Division, Centre for Addiction and Mental Health (CAMH), Toronto, Ontario, Canada; Division of Brain and Therapeutics, Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09209964173026
Publisher Site
http://dx.doi.org/10.1016/j.schres.2017.05.006DOI Listing
April 2018

Rapid vs. slow antipsychotic initiation in schizophrenia: A systematic review and meta-analysis.

Schizophr Res 2018 03 23;193:29-36. Epub 2017 Aug 23.

Schizophrenia Division, Complex Care & Recovery Program, Centre for Addiction and Mental Health, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2017.08.012DOI Listing
March 2018

Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.

Psychiatry Res Neuroimaging 2018 03 31;273:16-24. Epub 2018 Jan 31.

Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Geriatric Mental Health Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Campbell Institute Research Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pscychresns.2018.01.004DOI Listing
March 2018

Reward motivation in humans and its relationship to dopamine D receptor availability: A pilot study with dual [C]-raclopride and [C]-(+)-PHNO imaging.

J Psychopharmacol 2018 03 14;32(3):357-366. Epub 2018 Feb 14.

1 Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0269881118756059DOI Listing
March 2018

Investigating the predictors of happiness, life satisfaction and success in schizophrenia.

Compr Psychiatry 2018 02 22;81:42-47. Epub 2017 Nov 22.

Centre for Addiction and Mental Health, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0010440X173025
Publisher Site
http://dx.doi.org/10.1016/j.comppsych.2017.11.005DOI Listing
February 2018

Reduced insulin sensitivity may be related to less striatal glutamate: An H-MRS study in healthy non-obese humans.

Eur Neuropsychopharmacol 2018 02;28(2):285-296

Research Imaging Centre, Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario, Canada M5T 1R8; Department of Psychiatry, University of Toronto, 250 College Street, Toronto, Ontario, Canada M5T 1R8; Institute of Medical Science, University of Toronto, 2374 Medical Sciences Building, 1 King's College Circle, Toronto, Ontario, Canada M5S 1A8. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euroneuro.2017.12.002DOI Listing
February 2018

Gradual vs. wait-and-gradual discontinuation in antipsychotic switching: A meta-analysis.

Schizophr Res 2017 11 27;189:4-8. Epub 2017 Feb 27.

Schizophrenia Division, Complex Care & Recovery Program, Centre for Addiction and Mental Health, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2017.02.011DOI Listing
November 2017

The relationship between subcortical brain volume and striatal dopamine D receptor availability in healthy humans assessed with [ C]-raclopride and [ C]-(+)-PHNO PET.

Hum Brain Mapp 2017 11 28;38(11):5519-5534. Epub 2017 Jul 28.

Research Imaging Centre, Centre for Addiction and Mental Health, 250 College Street, Toronto, Ontario, M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hbm.23744DOI Listing
November 2017

The effects of buspirone on occupancy of dopamine receptors and the rat gambling task.

Psychopharmacology (Berl) 2017 Nov 19;234(22):3309-3320. Epub 2017 Aug 19.

Translational Addiction Research Laboratory, Centre for Addiction and Mental Health (CAMH), University of Toronto, 33 Russell Street, Toronto, M5S 2S1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00213-017-4715-5DOI Listing
November 2017

In male rats, the ability of central insulin to suppress glucose production is impaired by olanzapine, whereas glucose uptake is left intact.

J Psychiatry Neurosci 2017 11 16;42(6):170092. Epub 2017 Oct 16.

From the Centre for Addiction and Mental Health, Toronto, Ont., Canada (Kowalchuk, Teo, Wilson, Chintoh, Agarwal, Remington, Hahn); the Institute of Medical Sciences, University of Toronto, Toronto, Ont., Canada (Kowalchuk, Giacca, Remington, Hahn); the Department of Psychiatry, University of Toronto, Toronto, Ont., Canada (Chintoh, Remington, Hahn); and the Department of Physiology, University of Toronto, Toronto, Ont., Canada (Lam, Giacca).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1503/jpn.170092DOI Listing
November 2017

In male rats, the ability of central insulin to suppress glucose production is impaired by olanzapine, whereas glucose uptake is left intact.

J Psychiatry Neurosci 2017 Nov;42(6):424-431

From the Centre for Addiction and Mental Health, Toronto, Ont., Canada (Kowalchuk, Teo, Wilson, Chintoh, Agarwal, Remington, Hahn); the Institute of Medical Sciences, University of Toronto, Toronto, Ont., Canada (Kowalchuk, Giacca, Remington, Hahn); the Department of Psychiatry, University of Toronto, Toronto, Ont., Canada (Chintoh, Remington, Hahn); and the Department of Physiology, University of Toronto, Toronto, Ont., Canada (Lam, Giacca).

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5662464PMC
November 2017

Factors associated with drug attitude in patients with schizophrenia spectrum disorders.

Schizophr Res 2017 10 25;188:185-186. Epub 2017 Jan 25.

Schizophrenia Division, Complex Care & Recovery Program, Centre for Addiction and Mental Health, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2017.01.033DOI Listing
October 2017

Trait impulsiveness is related to smaller post-commissural putamen volumes in males but not females.

Eur J Neurosci 2017 Oct 4;46(7):2253-2264. Epub 2017 Sep 4.

Research Imaging Centre, Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejn.13661DOI Listing
October 2017

One-year symptom trajectories in patients with stable schizophrenia maintained on antipsychotics versus placebo: meta-analysis.

Br J Psychiatry 2017 Sep 18;211(3):137-143. Epub 2017 May 18.

Hiroyoshi Takeuchi, MD, PhD, Schizophrenia Division, Complex Care & Recovery Program, Centre for Addiction and Mental Health, Toronto, Department of Psychiatry, University of Toronto, Toronto, Canada, and Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan; Navot Kantor, BSc, Faculty of Medicine, University of Ottawa, Ottawa, Canada; Marcos Sanches, MSc, Biostatistical Consulting Service, Clinical Research Department, Centre for Addiction and Mental Health, Toronto, Canada; Gagan Fervaha, BSc, Schizophrenia Division, Complex Care & Recovery Program, Centre for Addiction and Mental Health, Toronto, and Institute of Medical Science, University of Toronto, Toronto, Canada; Ofer Agid, MD, Schizophrenia Division, Complex Care & Recovery Program, Centre for Addiction and Mental Health, Toronto, Department of Psychiatry and Institute of Medical Science, University of Toronto, Toronto, Canada; Gary Remington, MD, PhD, FRCPC, Schizophrenia Division, Complex Care & Recovery Program, Centre for Addiction and Mental Health, Toronto, Department of Psychiatry and Institute of Medical Science, University of Toronto, Toronto, and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1192/bjp.bp.116.186007DOI Listing
September 2017

Guidelines for the Pharmacotherapy of Schizophrenia in Adults.

Can J Psychiatry 2017 09 13;62(9):604-616. Epub 2017 Jul 13.

8 Department of Psychiatry, Dalhousie University, Halifax, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0706743717720448DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593252PMC
September 2017

Canadian Treatment Guidelines for Individuals at Clinical High Risk of Psychosis.

Can J Psychiatry 2017 09 21;62(9):656-661. Epub 2017 Jul 21.

3 Department of Psychiatry and Psychological Clinical Science, University of Toronto, Toronto, Ontario.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0706743717719895DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593244PMC
September 2017

Rat brain CYP2D enzymatic metabolism alters acute and chronic haloperidol side-effects by different mechanisms.

Prog Neuropsychopharmacol Biol Psychiatry 2017 08 26;78:140-148. Epub 2017 Apr 26.

Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute, Toronto, Canada; Department of Pharmacology and Toxicology, University of Toronto, Canada; Department of Psychiatry, University of Toronto, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pnpbp.2017.04.030DOI Listing
August 2017

Investigating consummatory and anticipatory pleasure across motivation deficits in schizophrenia and healthy controls.

Psychiatry Res 2017 08 23;254:112-117. Epub 2017 Apr 23.

Centre for Addiction and Mental Health, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01651781163210
Publisher Site
http://dx.doi.org/10.1016/j.psychres.2017.04.040DOI Listing
August 2017

Valbenazine for Tardive Dyskinesia.

Clin Schizophr Relat Psychoses Summer 2017;11(2):113-119

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3371/CSRP.OFGR.071717DOI Listing
August 2017

Immediate vs Gradual Discontinuation in Antipsychotic Switching: A Systematic Review and Meta-analysis.

Schizophr Bull 2017 07;43(4):862-871

Schizophrenia Division, Complex Care & Recovery Program, Centre for Addiction and Mental Health, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
https://academic.oup.com/schizophreniabulletin/article-looku
Publisher Site
http://dx.doi.org/10.1093/schbul/sbw171DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472156PMC
July 2017

Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning.

Psychoneuroendocrinology 2017 Jul 31;81:80-87. Epub 2017 Mar 31.

Department of Psychiatry, University of British Columbia, Detwiller Pavilion, 2255 Wesbrook Mall, Vancouver, British Columbia, V6T 2A1, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psyneuen.2017.03.020DOI Listing
July 2017

GWAS analysis of treatment resistant schizophrenia: interaction effect of childhood trauma.

Pharmacogenomics 2017 May 28;18(7):663-671. Epub 2017 Apr 28.

EEG & Genetics Group, Centre for Addiction & Mental Health, 250 College Street, Toronto, Ontario, M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2016-0137DOI Listing
May 2017

Neurocognitive Benefits of Second-Generation Antipsychotics Versus Placebo: Insufficient Evidence Based on a Systematic Review.

J Clin Psychopharmacol 2017 04;37(2):274-276

Schizophrenia Division, Complex Care & Recovery Program, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto, Toronto, Canada and Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan Schizophrenia Division, Complex Care & Recovery Program, Centre for Addiction and Mental Health and Department of Anthropology, University of Toronto, Toronto, Canada; Schizophrenia Division, Complex Care & Recovery Program, Centre for Addiction and Mental Health and Institute of Medical Science, University of Toronto, Toronto, Canada; Schizophrenia Division, Complex Care & Recovery Program, Centre for Addiction and Mental Health and Department of Psychiatry, University of Toronto and Institute of Medical Science, University of Toronto and Campbell Family Mental, Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0000000000000662DOI Listing
April 2017

Effect of antipsychotic pharmacotherapy on clinical outcomes of intermittent theta-burst stimulation for refractory depression.

J Psychopharmacol 2017 03 11;31(3):312-319. Epub 2016 Nov 11.

1 MRI-Guided rTMS Clinic, Department of Psychiatry, University Health Network, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0269881116675516DOI Listing
March 2017

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

Am J Psychiatry 2017 Mar 6;174(3):216-229. Epub 2016 Dec 6.

From King's College London, Institute of Psychiatry, Psychology, and Neuroscience; MRC Clinical Sciences Centre; Institute of Clinical Sciences, Imperial College, and Hammersmith Hospital London; the Department of Psychiatry, University of Toronto, and the Centre for Addiction and Mental Health, Toronto; the Section of Psychiatry and Treatment Resistant Psychosis and the Laboratory of Translational Psychiatry, School of Medicine of Naples Federico II, Naples; the Departments of Psychiatry and Neuroscience, Erasmus Medical Center, and Antes Mental Health Care, Rotterdam, the Netherlands; the Feinstein Institute for Medical Research, Psychiatry Research, Zucker Hillside Hospital, Hofstra Northwell School of Medicine; the Division of Psychiatry, University College London; Laboratorio Interdisciplinar de Neurociencia Clinica, Universidade Federal de São Paulo, São Paulo; the Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland School of Medicine, Baltimore; the University of Melbourne and St. Vincent's Hospital, Sydney; the Department of Psychiatry and Behavioral Sciences, New York Medical College, New York; the Department of Psychiatry, Tel Aviv University, Tel Aviv; the Division of Health Sciences, School of Psychology and Mental Health, Faculty of Biology, Medicine, and Health, University of Manchester, and the Manchester Academic Health Science Centre, Manchester Mental Health and Social Care NHS Trust, Manchester; the Department of Psychiatry, University of Alberta, Edmonton; the Center for Neuropsychiatric Schizophrenia Research and the Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, Mental Health Center Glostrup, University of Copenhagen, Copenhagen; the Department of Psychiatry, University of São Paulo Medical School, São Paulo; the Department of Psychiatry, University of Munich, Munich; the Department of Psychiatry, Psychotherapy, and Psychosomatics, Medical University Innsbruck, Innsbruck, Austria; Programa de Esquizofrenia and Laboratorio Interdisciplinar de Neurociencia Clinica, Universidade Federal de São Paulo, São Paulo; the National Psychosis Service, South London and Maudsley NHS Foundation Trust; the Neuroscience and Behavior Department, School of Medicine of Ribeirão Preto, University of São Paulo, São Paulo; the Department of Psychiatry, University of British Columbia; Lundbeck LLC, Deerfield, Ill.; University Department of Psychiatry, Royal Edinburgh Hospital, Edinburgh; the Department of General Psychiatry, Institute of Mental Health, Singapore; the Deparment of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Heidelberg; the Brain and Mind Centre, University of Sydney, Sydney; the School of Pharmacy, University of Auckland, Auckland, New Zealand; the Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago; the Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Munich; the Department of Neuropsychiatry, School of Medicine, Keio University, Tokyo; the Department of Psychiatry, Melbourne Neuropsychiatry Centre, University of Melbourne, and Melbourne Health, Victoria; the Schizophrenia Division, Centre for Addiction and Mental Health, Toronto; the Centre for Mental Health, Swinburne University, the Monash Alfred Psychiatry Research Centre, and the Department of Psychiatry, St. Vincent's Hospital Melbourne, Sydney; the School of Pharmacy, University of Otago, Otago, New Zealand; COS and Associates Ltd., Hong Kong; the Department of Neuropsychiatry, Keio University School of Medicine, Keio, Japan; the Department of Neuroscience, University Medical Center Utrecht, Utrecht, the Netherlands; Swinburne University and Monash Alfred Psychiatry Research Centre, Brain and Psychological Sciences Research Centre, Melbourne; the Istanbul Faculty of Medicine, Istanbul University, Istanbul; Clinical Research and Early Development, F. Hoffmann -La Roche Ltd., Basel, Switzerland; the Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, and the MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff; Psychiatry Research, Zucker Hillside Hospital, Long Island Jewish Medical Center, Hofstra Northwell School of Medicine, and the Feinstein Institute for Medical Research, New York.

View Article

Download full-text PDF

Source
http://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2016.16
Publisher Site
http://dx.doi.org/10.1176/appi.ajp.2016.16050503DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231547PMC
March 2017

Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [F]FEPPA.

Am J Psychiatry 2017 Feb 9;174(2):118-124. Epub 2016 Sep 9.

From the Research Imaging Centre and the Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto; the Departments of Psychiatry and of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto; and the Institute of Medical Science, University of Toronto, Toronto.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1176/appi.ajp.2016.16020171DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342628PMC
February 2017

Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.

J Clin Psychiatry 2017 02;78(2):223-228

Schizophrenia Division, Centre for Addiction and Mental Health, 250 College St, Toronto, Ontario, M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.15m10286DOI Listing
February 2017

Pharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine.

Mol Neuropsychiatry 2017 Feb 12;2(4):185-197. Epub 2016 Oct 12.

Neuroscience Research Department, Campbell Family Research Institute, Toronto, Ont., Canada; Institute of Medical Science, Toronto, Ont., Canada; Department of Psychiatry, University of Toronto, Toronto, Ont., Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000449224DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318922PMC
February 2017

Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia.

Prog Neuropsychopharmacol Biol Psychiatry 2017 01 24;72:23-29. Epub 2016 Aug 24.

Centre for Addiction and Mental Health, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pnpbp.2016.08.010DOI Listing
January 2017

Association study between the neurexin-1 gene and tardive dyskinesia.

Hum Psychopharmacol 2017 01;32(1)

Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hup.2568DOI Listing
January 2017

Practice and Learning: Spatiotemporal Differences in Thalamo-Cortical-Cerebellar Networks Engagement across Learning Phases in Schizophrenia.

Front Psychiatry 2016 23;7:212. Epub 2017 Jan 23.

Rotman Research Institute of Baycrest Health Sciences, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://journal.frontiersin.org/article/10.3389/fpsyt.2016.00
Publisher Site
http://dx.doi.org/10.3389/fpsyt.2016.00212DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5256117PMC
January 2017

Personal Recovery in Serious Mental Illness: Making Sense of the Concept.

Ann Acad Med Singapore 2017 Jan;46(1):29-31

Department of General Psychiatry 1, Institute of Mental Health, Singapore.

View Article

Download full-text PDF

Source
January 2017

Incidence of Antipsychotic-Associated Side Effects: Impact of Clinician Versus Patient Ratings and Change Versus Absolute Scores.

J Clin Psychopharmacol 2016 Dec;36(6):593-596

From the *Schizophrenia Division, Centre for Addiction and Mental Health; and †Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; ‡Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan; and §Institute of Medical Science, University of Toronto; and ‖Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0000000000000569DOI Listing
December 2016

The effect of an acute bout of exercise on executive function among individuals with schizophrenia.

Psychiatry Res 2016 Dec 1;246:637-643. Epub 2016 Nov 1.

School of Kinesiology, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2016.10.075DOI Listing
December 2016

Estimating the effect of endogenous dopamine on baseline [(11) C]-(+)-PHNO binding in the human brain.

Synapse 2016 11 11;70(11):453-60. Epub 2016 Jul 11.

Centre for Addiction and Mental Health, Research Imaging Centre, Toronto, Ontario, M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/syn.21920DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328677PMC
November 2016

Using poverty of speech as a case study to explore the overlap between negative symptoms and cognitive dysfunction.

Schizophr Res 2016 10 27;176(2-3):411-416. Epub 2016 May 27.

Schizophrenia Division and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2016.05.019DOI Listing
October 2016

What symptom domains are associated with patient distress in schizophrenia?

Schizophr Res 2016 10 31;176(2-3):329-330. Epub 2016 May 31.

Schizophrenia Division, Complex Mental Illness Program, Centre for Addiction and Mental Health, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2016.05.020DOI Listing
October 2016

Reliability of a patient-reported outcome measure in schizophrenia: Results from back-to-back self-ratings.

Psychiatry Res 2016 Oct 27;244:415-9. Epub 2016 Jul 27.

Schizophrenia Division, Centre for Addiction and Mental Health, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2016.07.055DOI Listing
October 2016

A preliminary examination of the validity and reliability of a new brief rating scale for symptom domains of psychosis: Brief Evaluation of Psychosis Symptom Domains (BE-PSD).

J Psychiatr Res 2016 09 8;80:87-92. Epub 2016 Jun 8.

Schizophrenia Division, Complex Mental Illness Program, Centre for Addiction and Mental Health, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00223956163011
Publisher Site
http://dx.doi.org/10.1016/j.jpsychires.2016.06.005DOI Listing
September 2016

Association Between Weight Gain and Remission Status at 3 Months in First-Episode Schizophrenia.

J Clin Psychopharmacol 2016 Aug;36(4):403-5

Research Division Institute of Mental Health Singapore Schizophrenia Division Centre for Addiction and Mental Health and Department of Psychiatry University of Toronto Toronto, Ontario Canada Research Division Institute of Mental Health and Department of General Psychiatry 1 Institute of Mental Health and Office of Clinical Sciences Duke-NUS Graduate Medical School Singapore

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0000000000000513DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932151PMC
August 2016

Life satisfaction and happiness among young adults with schizophrenia.

Psychiatry Res 2016 Aug 1;242:174-179. Epub 2016 Jun 1.

Schizophrenia Division and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2016.05.046DOI Listing
August 2016

Consistency between clinician and patient ratings of clozapine-induced side effects.

Schizophr Res 2016 07 16;174(1-3):200-201. Epub 2016 Apr 16.

Schizophrenia Division, Centre for Addiction and Mental Health, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2016.04.005DOI Listing
July 2016

Atypical antipsychotics and effects on feeding: from mice to men.

Psychopharmacology (Berl) 2016 Jul 1;233(14):2629-53. Epub 2016 Jun 1.

Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00213-016-4324-8DOI Listing
July 2016

Physical activity preferences of individuals diagnosed with schizophrenia or bipolar disorder.

BMC Res Notes 2016 Jul 12;9:340. Epub 2016 Jul 12.

School of Kinesiology, University of British Columbia, 2146 Health Sciences Mall, Room 4606, Vancouver, BC, V6T 1Z3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13104-016-2151-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941008PMC
July 2016

Quantifying intraindividual variations in plasma clozapine levels: a population pharmacokinetic approach.

J Clin Psychiatry 2016 05;77(5):681-7

Schizophrenia Division, Centre for Addiction and Mental Health, 250 College St, Toronto, Ontario M5T 1R8, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.14m09714DOI Listing
May 2016

Motivational deficits in major depressive disorder: Cross-sectional and longitudinal relationships with functional impairment and subjective well-being.

Compr Psychiatry 2016 Apr 18;66:31-8. Epub 2015 Dec 18.

Schizophrenia Division and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0010440X153001
Publisher Site
http://dx.doi.org/10.1016/j.comppsych.2015.12.004DOI Listing
April 2016

Drs Lee and Remington Reply.

J Clin Psychiatry 2016 04;77(4):e468

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4088/JCP.15lr10392aDOI Listing
April 2016

Treating Negative Symptoms in Schizophrenia: an Update.

Curr Treat Options Psychiatry 2016;3:133-150. Epub 2016 Apr 8.

Department of Psychiatry, University of Toronto, Toronto, ON Canada ; Institute of Medical Science, University of Toronto, Toronto, ON Canada ; Centre for Addiction and Mental Health (CAMH), 250 College St., Toronto, ON M5T 1R8 Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40501-016-0075-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908169PMC
April 2016

Characterizing the affective responses to an acute bout of moderate-intensity exercise among outpatients with schizophrenia.

Psychiatry Res 2016 Mar 28;237:264-70. Epub 2016 Jan 28.

Faculty of Kinesiology & Physical Education, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.psychres.2016.01.030DOI Listing
March 2016

Genetic association analysis of N-methyl-D-aspartate receptor subunit gene GRIN2B and clinical response to clozapine.

Hum Psychopharmacol 2016 Mar 15;31(2):121-34. Epub 2016 Feb 15.

Neurogenetics Section, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hup.2519DOI Listing
March 2016

Insight and subjective measures of quality of life in chronic schizophrenia.

Schizophr Res Cogn 2015 Sep 9;2(3):127-132. Epub 2015 Jun 9.

Center for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scog.2015.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788499PMC
September 2015